There are now more cannabis products available through the medical pathway at a cheaper price. Over 10% cheaper compared with this time last year according to Canview.
Canview is owned by CDA clinics. We’ve met the team at CDA. And from our experience, they were great people on a good mission.
If people are unwell and are able to access a wider range of quality cannabis products at a cheaper price through the medical pathway, this is a good thing. We’re not complaining.
If anybody has recently purchased CBD through the medical pathway and can vouch that prices have dropped, please let us know in the comments below.
We often have people come to us and tell us we should not be supporting the ‘green market’ as medical cannabis prices in Australia are actually very reasonable and becoming cheaper.
Medical cannabis products are certainly becoming cheaper.
We would however, like to take this opportunity to highlight a couple of very important considerations.
CBD Isolate and Full Spectrum CBD are not the same thing
There is a lot of misinformation about CBD oil.
It’s important to understand the difference between Full Spectrum and Isolate products. Many companies are selling cheap CBD oil products in isolate form in Australia. An isolate is incredibly cheap to produce as the CBD is extracted and ground into crystal form easy to scale and reproduce.
From what I can see, the 11% yearly price reduction has come about largely because medical providers are selling previously incredibly overpriced isolate products at a much cheaper rate.
While it’s cheap, it does not have all the benefits of the plant that come from its natural, full spectrum state. You are missing out on all the wonderful terpenes, flavonoids etc. It’s also been shown that all the cannabinoids come together to form a synergistic ‘entourage effect’ whereby the combined compounds have and effect far greater than the individual compounds combined. Mother nature’s magic.
I recently ordered CBD through the medical market, it was cheap, but it was an isolate product. There was no education provided to me about this, the doctor couldn’t even tell me what I was taking and had no interest in my condition.
If the medical pathway is going to promote ‘cheaper products’ they should have the responsibility of educating their patients more about the plant and the cannabinoids.
If you’d like to explore the science more, our friends from Project CBD have a great piece. https://www.projectcbd.org/science/pure-cbd-better
The reason a quality, full spectrum product is more expensive, is because (hopefully) it’s grown the way nature intended, not isolated for replication of certain compounds in a lab. Ideally, organically gown, outside in the sunshine.
It doesn’t take a huge leap of imagination to see what could potentially go wrong here.
I personally think we’re entering the early stages of a very degenerative battle. Medical cannabis is going to continually attempt to reduce product costs to compete with the green market by creating isolate products and reducing the quality of service and education.
Everyone is a loser in this scenario.
Yet another reason we need to push for adult use legalisation in this country.
If the goal is to really help people access the medical benefits of this incredible plant, we need to open the discussion and make some serious changes.